HomeYMAB • NASDAQ
add
Y-mAbs Therapeutics Inc
Previous close
$10.10
Day range
$9.93 - $10.49
Year range
$5.29 - $20.90
Market cap
466.25M USD
Avg Volume
244.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 18.46M | -9.74% |
Operating expense | 24.06M | -5.85% |
Net income | -7.00M | 9.67% |
Net profit margin | -37.91 | -0.08% |
Earnings per share | -0.16 | 11.11% |
EBITDA | -7.73M | -1.95% |
Effective tax rate | -5.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 68.12M | -21.31% |
Total assets | 120.92M | -6.18% |
Total liabilities | 28.49M | -0.86% |
Total equity | 92.43M | — |
Shares outstanding | 44.79M | — |
Price to book | 4.90 | — |
Return on assets | -14.81% | — |
Return on capital | -20.65% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.00M | 9.67% |
Cash from operations | -10.66M | -697.09% |
Cash from investing | — | — |
Cash from financing | 979.00K | — |
Net change in cash | -9.68M | -623.77% |
Free cash flow | -680.25K | 86.84% |
About
Founded
2015
Website
Employees
100
